BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34801042)

  • 1. Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study.
    Makita K; Hamamoto Y; Kanzaki H; Kataoka M; Yamamoto S; Nagasaki K; Ishikawa H; Takata N; Tsuruoka S; Uwatsu K; Kido T
    Radiat Oncol; 2021 Nov; 16(1):225. PubMed ID: 34801042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy.
    Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Takata N; Tsuruoka S; Uwatsu K; Kido T
    Med Sci (Basel); 2023 Feb; 11(1):. PubMed ID: 36810484
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting local control of bone metastases from radioresistant tumors treated with palliative external beam radiotherapy.
    Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Takata N; Tsuruoka S; Uwatsu K; Kido T
    Discov Oncol; 2023 May; 14(1):74. PubMed ID: 37212949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local control after palliative external beam radiotherapy for bone metastases in patients with favorable prognosis.
    Makita K; Hamamoto Y; Kanzaki H; Kataoka M; Yamamoto S; Nagasaki K; Ishikawa H; Takata N; Tsuruoka S; Uwatsu K; Kido T
    Mol Clin Oncol; 2022 Nov; 17(5):152. PubMed ID: 36237604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the types of pretreatment imaging modalities on the treatment response to palliative radiation for painful bone metastases from solid cancer: a single-center retrospective analysis.
    Wada Y; Anbai A; Kumagai S; Okuyama E; Hatakeyama K; Takagi N; Hashimoto M
    Radiat Oncol; 2019 Jun; 14(1):98. PubMed ID: 31174548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients.
    König L; Häfner MF; Katayama S; Koerber SA; Tonndorf-Martini E; Bernhardt D; von Nettelbladt B; Weykamp F; Hoegen P; Klüter S; Susko MS; Debus J; Hörner-Rieber J
    Radiat Oncol; 2020 Feb; 15(1):30. PubMed ID: 32019553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal stereotactic body radiotherapy dosage for hepatocellular carcinoma: a multicenter study.
    Su TS; Liu QH; Zhu XF; Liang P; Liang SX; Lai L; Zhou Y; Huang Y; Cheng T; Li LQ
    Radiat Oncol; 2021 Apr; 16(1):79. PubMed ID: 33882972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent use of strontium-89 with external beam radiotherapy for multiple bone metastases: early experience.
    Heianna J; Toita T; Endo W; Kasuya G; Ariga T; Hashimoto S; Maemoto H; Terui K; Miura N; Togashi A; Miyauchi T; Murayama S
    Ann Nucl Med; 2015 Dec; 29(10):848-53. PubMed ID: 26266885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy.
    He J; Zeng ZC; Tang ZY; Fan J; Zhou J; Zeng MS; Wang JH; Sun J; Chen B; Yang P; Pan BS
    Cancer; 2009 Jun; 115(12):2710-20. PubMed ID: 19382203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment intensity and control rates in combining external-beam radiotherapy and radioactive iodine therapy for metastatic or recurrent differentiated thyroid cancer.
    Makita K; Hamamoto Y; Tsuruoka S; Takata N; Urashima Y; Miyagawa M; Mochizuki T
    Int J Clin Oncol; 2020 Apr; 25(4):691-697. PubMed ID: 31897803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local control of bone metastasis treated with palliative radiotherapy in patients with lung cancer: An observational retrospective cohort study.
    Makita K; Hamamoto Y; Kanzaki H; Nagasaki K; Kozuki T
    Oncol Lett; 2023 Jul; 26(1):303. PubMed ID: 37323814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic Body Radiotherapy (SBRT) for liver metastasis - clinical outcomes from the international multi-institutional RSSearch® Patient Registry.
    Mahadevan A; Blanck O; Lanciano R; Peddada A; Sundararaman S; D'Ambrosio D; Sharma S; Perry D; Kolker J; Davis J
    Radiat Oncol; 2018 Feb; 13(1):26. PubMed ID: 29439707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stereotactic body radiotherapy for adrenal oligometastasis in lung cancer patients.
    Arcidiacono F; Aristei C; Marchionni A; Italiani M; Fulcheri CPL; Saldi S; Casale M; Ingrosso G; Anselmo P; Maranzano E
    Br J Radiol; 2020 Nov; 93(1115):20200645. PubMed ID: 32822540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A collaborative analysis of stereotactic lung radiotherapy outcomes for early-stage non-small-cell lung cancer using daily online cone-beam computed tomography image-guided radiotherapy.
    Grills IS; Hope AJ; Guckenberger M; Kestin LL; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Wilbert J; Xiao Y; Belderbos J
    J Thorac Oncol; 2012 Sep; 7(9):1382-93. PubMed ID: 22843086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Palliative external beam radiotherapy for the treatment of tumor bleeding in inoperable advanced gastric cancer.
    Lee YH; Lee JW; Jang HS
    BMC Cancer; 2017 Aug; 17(1):541. PubMed ID: 28800749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using max standardized uptake value from positron emission tomography to assess tumor responses after lung stereotactic body radiotherapy for different prescriptions.
    Ding M; Zollinger W; Ebeling R; Heard D; Posey R
    J Appl Clin Med Phys; 2018 Nov; 19(6):226-233. PubMed ID: 30216639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis.
    Foster CC; Sher DJ; Rusthoven CG; Verma V; Spiotto MT; Weichselbaum RR; Koshy M
    Radiat Oncol; 2019 Jan; 14(1):18. PubMed ID: 30691492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Planning Target Volume D95 and Mean Dose Should Be Considered for Optimal Local Control for Stereotactic Ablative Radiation Therapy.
    Zhao L; Zhou S; Balter P; Shen C; Gomez DR; Welsh JD; Lin SH; Chang JY
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1226-35. PubMed ID: 27209498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intraoperative radiation therapy for the treatment of recurrent retroperitoneal and pelvic tumors: a single-institution analysis.
    Coelho TM; Fogaroli RC; Pellizzon ACA; De Castro DG; Gondim GRM; Silva MLG; Chen MJ; Ramos H
    Radiat Oncol; 2018 Nov; 13(1):224. PubMed ID: 30454036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion.
    Hou JZ; Zeng ZC; Zhang JY; Fan J; Zhou J; Zeng MS
    Int J Radiat Oncol Biol Phys; 2012 Oct; 84(2):362-8. PubMed ID: 22381903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.